These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28791417)

  • 1. Diverse gene expression patterns in response to anticancer drugs between human and mouse cell lines revealed by a comparative transcriptomic analysis.
    Guo Y; Liang Z; Hou X; Zhang Z
    Mol Med Rep; 2017 Oct; 16(4):4469-4474. PubMed ID: 28791417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
    Lee H; Kang S; Kim W
    PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs.
    Venkova L; Aliper A; Suntsova M; Kholodenko R; Shepelin D; Borisov N; Malakhova G; Vasilov R; Roumiantsev S; Zhavoronkov A; Buzdin A
    Oncotarget; 2015 Sep; 6(29):27227-38. PubMed ID: 26317900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation.
    Mashima T; Ushijima M; Matsuura M; Tsukahara S; Kunimasa K; Furuno A; Saito S; Kitamura M; Soma-Nagae T; Seimiya H; Dan S; Yamori T; Tomida A
    Cancer Sci; 2015 Jul; 106(7):909-20. PubMed ID: 25911996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
    Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
    Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.
    Yin X; Luistro L; Zhong H; Smith M; Nevins T; Schostack K; Hilton H; Lin TA; Truitt T; Biondi D; Wang X; Packman K; Rosinski J; Berkofsky-Fessler W; Tang JP; Pant S; Geho D; Vega-Harring S; Demario M; Levitsky H; Simcox M
    Clin Cancer Res; 2013 Oct; 19(20):5686-98. PubMed ID: 23974006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes.
    Balestrieri C; Vanoni M; Hautaniemi S; Alberghina L; Chiaradonna F
    Biotechnol Adv; 2012; 30(1):16-29. PubMed ID: 21736933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen.
    Covell DG
    PLoS One; 2012; 7(10):e44631. PubMed ID: 23056181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular within and between score for drug response prediction in cancer cell lines.
    Wang S; Li J
    Mol Omics; 2020 Feb; 16(1):31-38. PubMed ID: 31802092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma.
    Ghasemi M; Alpsoy S; Türk S; Malkan ÜY; Atakan Ş; Haznedaroğlu İC; Güneş G; Gündüz M; Yılmaz B; Etgül S; Aydın S; Aslan T; Sayınalp N; Aksu S; Demiroğlu H; Özcebe OI; Büyükaşık Y; Göker H
    Turk J Haematol; 2016 Dec; 33(4):286-292. PubMed ID: 27095044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
    Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
    BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
    Covell DG
    PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
    Huang R; Wallqvist A; Thanki N; Covell DG
    Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction.
    Huang C; Ba Q; Yue Q; Li J; Li J; Chu R; Wang H
    Mol Biosyst; 2013 Dec; 9(12):3091-100. PubMed ID: 24085322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of genotype-specific drug responses in cancer.
    Kim N; He N; Kim C; Zhang F; Lu Y; Yu Q; Stemke-Hale K; Greshock J; Wooster R; Yoon S; Mills GB
    Int J Cancer; 2012 Nov; 131(10):2456-64. PubMed ID: 22422301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
    McBryan J; Fagan A; McCartan D; Bane FT; Varešlija D; Cocchiglia S; Byrne C; Bolger J; McIlroy M; Hudson L; Tibbitts P; Gaora PÓ; Hill AD; Young LS
    Clin Cancer Res; 2015 Dec; 21(23):5371-9. PubMed ID: 26240272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data.
    Wallqvist A; Rabow AA; Shoemaker RH; Sausville EA; Covell DG
    Bioinformatics; 2003 Nov; 19(17):2212-24. PubMed ID: 14630650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors.
    Zhang J; Jia J; Zhu F; Ma X; Han B; Wei X; Tan C; Jiang Y; Chen Y
    Mol Biosyst; 2012 Oct; 8(10):2645-56. PubMed ID: 22833077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.